Surrogate Endpoints in Colorectal Cancer

G. Browman; A. Shah; J. Ayoub; R. Wong; J. Maroun; G. Batist

doi:10.3390/curroncol12040003

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 December 2005

Surrogate Endpoints in Colorectal Cancer

and

Department of Oncology, McGill University and Montreal Centre for Experimental Therapeutics in Cancer, Sir Mortimer B. Davis–Jewish General Hospital, 3755 Cote St-Catherine Road, Montreal, QC H3T 1E2, Canada

BC Cancer Agency, Vancouver, BC, Canada

Notre Dame Hospital, Montreal, QC, Canada

⁴

St. Boniface General Hospital, Winnipeg, MN, Canada

Curr. Oncol.2005, 12(4), 136-146;https://doi.org/10.3390/curroncol12040003

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

There is ongoing debate about the criteria that are required for a new treatment to be approved for prescription and reimbursement and for clinicians to be convinced of that treatment’s true clinical utility [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Cancer Stem Cells Revisited

Rationale for Extended Adjuvant Letrozole after Five Years of Tamoxifen in Postmenopausal Oestrogen Receptor–Positive Women with Early-Stage Breast Cancer